Elga prepares to enter a new dimension

Published: 1-May-2004

The Orion TTS is the latest addition to the Orion range


The Orion TTS (pictured) is the latest addition to ELGA Process Water's Orion range of packaged hot water sanitisable purified water plants and was shown in the UK for the first time.

A major new features of the TTS is the hot water sanitisable softeners for pretreatment of the feed water, included in response to demands from the pharma sector.

Another benefit is an improved touch-sensitive human/machine interface, together with a number of options in the software that can bolted on at low cost and automatic valve monitoring to ensure optimum flows. The units are prevalidated and have undergone fully documented Factory Acceptance Tests.

ELGA also offered potential customers a preview of its next major product. The Quattro - so called because it combines the four water treatment processes of softening, filtration, reverse osmosis and deionisation - is currently in the final stages of development trials and is due to be launched at Achema in September.

Quattro is an economical version of the Orion and operates on the same principle, although it is chemically rather than hot water sanitisable. It is being aimed at industrial applications such as cosmetics, non-critical pharmaceutical manufacturing, biotechnology, healthcare and electronics. It has a similar human/machine interface to the Orion, but is key-operated.

A range of optional and alternative treatment processes will be available, including a pharmaceutical option for USP/PH Eur Purified Water applications, which includes a UV disinfection unit, sanitary design of piping in contact with the product water and suitable validation packages. There will be four models in the Quattro range covering production rates from 500-3,000 litres/hour.

See more

You may also like

Manufacturing

Veolia increases hazardous waste capacity with new regional facility

Read more
This includes services on the customer's site to help classify and package waste, the collection at the point of production and on-site transfer and consolidation

Trending Articles

  1. Continuous innovation: redefining the future of pharmaceutical manufacturing In an industry in which reliability is paramount and change can be slow, GEA has consistently proven that innovation and stability go hand in hand. Almost two decades ago, GEA introduced the first ConsiGma® continuous manufacturing (CM) system to the pharmaceutical market — a pioneering move that helped to reshape how oral solid dosage (OSD) forms are developed and produced
  2. Abselion launches AAVX and AAV9 Total Capsid Quantification Kits Ready-to-use solution for Amperia benchtop platform supports rapid, reliable quantification across a range of serotypes
  3. diaago and Peak Analysis & Automation partner to bring practical automation solutions to research laboratories Using diaago's customer-first approach with PAA’s decades of expertise in laboratory robotics, the collaboration promises to deliver solutions to streamline workflows, boost throughput and reduce bottlenecks
  4. Suncombe and Kindeva collaborate to deliver low-carbon inhalers to the NHS The partnership will develop next-generation pressurised metered-dose inhalers with low Global Warming Potential propellants, helping the NHS move closer to its Net Zero target
  5. Douglas Pharmaceuticals sets new benchmark for capsule quality with CI Precision Partnership delivers compliance confidence, efficiency gains and reduced waste

Upcoming event

Enhancing probiotic stability through smarter formulation and packaging strategies

18 September 2025 | Virtual See all

You may also like

Manufacturing

Veolia increases hazardous waste capacity with new regional facility

This includes services on the customer's site to help classify and package waste, the collection at the point of production and on-site transfer and consolidation
Manufacturing

Veolia to host webinar on Cold Water for Injection (WFI)

Register to attend Veolia Water Technologies webinar on Cold WFI and how to manage the perceived risks associated with RO based systems for WFI production
Regulatory

Lab Innovations 2018 confirmed as a major hit with visitors, exhibitors and speakers

More visitors than ever before and organisers announce dates for next year’s show: 30-31st October 2019
Regulatory

Revised WFI guidelines offer greater choice of techniques

Distillation has long been the method of choice for the production of water for injection (WFI) for the biopharmaceutical industry. Although the United States and Japanese Pharmacopoeias have allowed the use of other technologies for some years, it was not until April 2017 that their European counterpart amended its guidelines to permit the use of alternative techniques that generate water of an equivalent quality
Manufacturing

Tackling water for injection at Making Pharmaceuticals UK 2018

Veolia Water Technologies (Veolia), a global leader in optimised resource management, is delighted to be exhibiting at Making Pharmaceuticals UK on the 24 – 25 April 2018 at the Ricoh Arena, Coventry
Regulatory

Veolia launches mobile chemist service

Chempac, the mobile chemist service, offers an easy way to manage and dispose of hazardous and chemical waste form the laboratory
Finance

When renting might be the better option

Capital expenditure and investment in a water infrastructure are critical to maintaining an ongoing high quality supply… but when might it be better to rent equipment instead of purchasing it?
Subscribe now